Certara Reports Third Quarter 2022 Financial Results

Biosimulation software and services fuel third quarter growth PRINCETON, N.J.— November 7, 2022– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the third quarter of fiscal year 2022 and reiterated its full year guidance. Third Quarter Highlights: Revenue was $84.7 million, compared to $73.9 million in the third … Continued

Tips to Use Phoenix WinNonlin More Efficiently

Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform is the single, interoperable hub for sharing pre-clinical and clinical knowledge across your organization. With Phoenix, you can create, manage, and leverage workflows that streamline your PK/PD data management and analysis. Here are some Phoenix tips to help you utilize Phoenix more efficiently.  Let’s start by making sure … Continued

The Role of PBPK Modeling & Simulation in Infants & Neonates

Many factors make it challenging to obtain adequate pediatric samples for use in drug development and to correctly determine doses. Age is an important factor because a drug may act very differently depending on the stage of the child’s development. Pharmacokinetic (PK) and pharmacodynamic (PD) studies are employed to determine optimal drug dosing in children … Continued

Certara to Participate in Upcoming Investor Conferences

PRINCETON, N.J.— November 2, 2022 — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor conferences: Jeffries London Healthcare ConferenceDate and Time: Tuesday, November 15 at 4:25PM GMT Stephens Annual Investment ConferenceDate and Time: Thursday, November 17 at 9:00AM CT Live webcasts for each … Continued

Certara’s Simcyp™ Co-Founders receive the 2022 Innovation Award by International Society of Pharmacometrics

ISoP recognizes innovative science and outstanding leadership in the field of Pharmacometrics and related scientific areas PRINCETON, NJ.— November 2, 2022 – Certara, Inc., the global leader in biosimulation, today announced that Amin Rostami, Ph.D and Geoff Tucker, Ph.D., co-founders of Simcyp (now, a division of Certara), have received the 2022 Innovation Award by the … Continued

1 of 43
Powered by Translations.com GlobalLink OneLink Software